Voyager Therapeutics Inc expected to post a loss of 32 cents a share - Earnings Preview

Voyager Therapeutics

04/11/2022 19:34

* Voyager Therapeutics Inc  VYGR.OQ   VYGR.O  is expected
to show
a rise in quarterly revenue when it reports  results on November
8. 
    * The Cambridge Massachusetts-based  company is expected to
report
 a 535.4% increase in revenue to $9.416 million from $1.48
million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Voyager
Therapeutics Inc
is for a loss of 32 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Voyager
Therapeutics Inc is $7.5​, above​ its last closing price
of $5.18. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.48       -0.32      -0.50     Missed  -57.5
 Mar. 31 2022  -0.25       -0.34      -0.56     Missed  -62.7
 Dec. 31 2021  -0.71       -0.32      0.15      Beat    147.4​
 Sep. 30 2021  -0.74       -0.73      -0.67     Beat    7.9
 ​​Jun.        -0.72       -0.71      -0.80     Missed  -12.3
 30 2021                                                
 Mar. 31 2021  -0.66       -0.66      -0.58     Beat    11.6​
 Dec. 31 2020  -0.57       -0.57      -0.43     Beat    23.9
 Sep. 30 2020  -0.24       -0.19      2.27      Beat    1,286.
                                                        9
 This summary was machine generated November 4 at 19:33 GMT.  All
figures in US dollars  unless otherwise stated